1. Millner LM, Strotman LN. The future of precision medicine in oncology. Clin Lab Med. 2016;36(3):557–73. https://doi.org/10.1016/j.cll.2016.05.003.
2. Bailey AM, Mao Y, Zeng J, et al. Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps. Discov Med. 2014;17(92):101–114. https://pubmed.ncbi.nlm.nih.gov/24534473.
3. Noone A, Howlader N, Krapcho M. SEER cancer statistics review, 1975–2015: lung and bronchus cancer. https://seer.cancer.gov/archive/csr/1975_2015/results_merged/sect_15_lung_bronchus.pdf. Published 2017. Accessed 29 June 2020.
4. Non-small cell lung cancer (version 7.2019). National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed 1 Nov 2019.
5. Bironzo P, Di Maio M. A review of guidelines for lung cancer. J Thorac Dis. 2018;10(Suppl 13):S1556–63. https://doi.org/10.21037/jtd.2018.03.54.